Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,319 across all filing types
Latest filing 2024-04-25 Regulatory Filings
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, PureTech Health plc, with the SEC. It references a press release titled 'PureTech Announces Annual Results for Year Ended December 31, 2023' which is furnished as an exhibit. The document itself is short (1713 characters) and primarily serves to announce the press release rather than containing the full annual report or detailed financial data. According to the 'MENU VS MEAL' rule, such a document is an announcement of a report rather than the report itself. Therefore, it should be classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other categories and includes announcements of reports.
2024-04-25 English
Final Results
Regulatory Filings Classification · 98% confidence The document is an RNS announcement dated April 25, 2024, titled 'PureTech Announces Annual Results for Year Ended December 31, 2023'. It provides select highlights from the full UK Annual Report and Accounts and mentions that the full report will be filed later today as an exhibit to the Form 20-F with the SEC. Crucially, the text states: 'PureTech Health will release its Annual Report for the year ended December 31, 2023, on April 25, 2024, later today.' It also lists the documents being submitted to the National Storage Mechanism, including the 'Annual Report and Accounts for the year ended December 31, 2023' and the 'Notice of 2024 Annual General Meeting'. Because this document is an announcement *about* the release of the Annual Report and other materials, and it is published via RNS, it fits the definition of a Report Publication Announcement (RPA) or, more generally, a Regulatory Filing (RNS). Given the explicit mention of submitting documents to the National Storage Mechanism (a regulatory requirement) and the nature of the announcement, RNS is the most appropriate general classification, although RPA is also highly relevant. Since the document is an announcement of the release of the 10-K/Annual Report, and not the full 10-K itself, RPA or RNS is preferred over 10-K. RNS is the broader regulatory filing category for such announcements.
2024-04-25 English
Notice of Results
Report Publication Announcement Classification · 99% confidence The document is a short announcement (4845 characters) released via RNS (London Stock Exchange news service). The core content states that PureTech Health plc 'plans to publish its Annual Report and Accounts and financial results for the year ended December 31, 2023, on Thursday, April 25, 2024.' It also mentions a subsequent presentation and conference call. Because the document is an announcement *about* the future publication of reports (Annual Report and financial results) rather than the reports themselves, it fits the definition of a Report Publication Announcement (RPA). It is not the full 10-K or IR, but a notice of their upcoming release.
2024-04-18 English
PRTC LYT-100 Ph2b in IPF Enrolled; Results Q4 2024
Regulatory Filings Classification · 100% confidence The document is identified by the header 'RNS Number : 7281K' and concludes with text stating, 'This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange.' This strongly indicates the document is a regulatory news service announcement. The content is a press release announcing the completion of enrollment in a clinical trial (ELEVATE IPF) and providing updates on drug development (LYT-100). This type of general, time-sensitive corporate announcement that doesn't fit into specific categories like 10-K, ER, or DIV, is best classified as a Regulatory Filing (RNS), which serves as the general regulatory announcement category.
2024-04-16 English
FDA Grants PRTC's LYT-200 Fast Track Designation
Regulatory Filings Classification · 95% confidence The document is a press release dated April 11, 2024, announcing that PureTech Health received FDA Fast Track designation for its drug LYT-200. It details clinical trial progress and scientific rationale. The document is distributed via RNS (Regulatory News Service) and contains standard press release formatting, including contact information and a cautionary note referencing the Form 20-F (Annual Report). Since this is an announcement of a specific corporate/clinical development event, and not a full financial report (10-K, IR, ER) or a general regulatory filing fallback (RNS), it best fits the category for general corporate news releases that are not specifically about earnings, dividends, or management changes. However, given the options, this type of announcement—a press release detailing clinical progress and regulatory milestones—is often categorized broadly. It is not a Call Transcript (CT), Earnings Release (ER), or a formal statutory filing like 10-K or AR. It is a specific corporate update. Since there isn't a specific 'Clinical Update' or 'Press Release' code, and it is a general announcement distributed via RNS, the most appropriate classification among the provided specific codes is difficult. It is not a Director's Dealing (DIRS), Dividend (DIV), or Capital Change (CAP). It is a significant corporate event announcement. Given the context of RNS distribution and the nature of the content (a press release about a regulatory/clinical milestone), it is a general regulatory announcement. If 'RNS' is used as a fallback for general announcements not covered elsewhere, it applies. However, if we look for the closest fit for a major corporate announcement that isn't financial results, it's still a general announcement. I will classify this as RNS as it is distributed via RNS and is a general regulatory announcement that doesn't fit the more specific financial or governance codes.
2024-04-11 English
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, PureTech Health plc, with the SEC. It contains a press release about launching a new company with a $100 million Series A financing and management transitions. The document is short (1759 characters) and primarily announces a press release rather than providing detailed financial data or a full report. It is not an annual or interim report, audit report, or earnings release. The content focuses on capital raising and management changes, but since it is a press release included in a 6-K filing, it is best classified as a Regulatory Filing (RNS), which is the fallback for miscellaneous filings and announcements that do not fit other categories. The document does not contain detailed financial statements or comprehensive management discussion, so it is not a Capital/Financing Update (CAP) report itself, but rather a regulatory announcement of such events.
2024-04-09 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.